nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—SLCO1B3—Methotrexate—multiple sclerosis	0.0846	0.141	CbGbCtD
Fluvastatin—CYP2D6—Fingolimod—multiple sclerosis	0.0679	0.113	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—multiple sclerosis	0.0493	0.082	CbGbCtD
Fluvastatin—CYP1A1—Dexamethasone—multiple sclerosis	0.045	0.0748	CbGbCtD
Fluvastatin—CYP3A4—Fingolimod—multiple sclerosis	0.0432	0.0718	CbGbCtD
Fluvastatin—CYP2C19—Prednisone—multiple sclerosis	0.0349	0.058	CbGbCtD
Fluvastatin—CYP2B6—Dexamethasone—multiple sclerosis	0.0343	0.057	CbGbCtD
Fluvastatin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0278	0.0463	CbGbCtD
Fluvastatin—CYP3A5—Dexamethasone—multiple sclerosis	0.027	0.0449	CbGbCtD
Fluvastatin—CYP2C8—Dexamethasone—multiple sclerosis	0.026	0.0432	CbGbCtD
Fluvastatin—CYP2C19—Dexamethasone—multiple sclerosis	0.0218	0.0362	CbGbCtD
Fluvastatin—CYP3A4—Triamcinolone—multiple sclerosis	0.0211	0.0351	CbGbCtD
Fluvastatin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0203	0.0338	CbGbCtD
Fluvastatin—CYP2C9—Dexamethasone—multiple sclerosis	0.0181	0.0301	CbGbCtD
Fluvastatin—CYP3A4—Betamethasone—multiple sclerosis	0.0181	0.0301	CbGbCtD
Fluvastatin—CYP3A4—Prednisolone—multiple sclerosis	0.0179	0.0297	CbGbCtD
Fluvastatin—CYP3A4—Prednisone—multiple sclerosis	0.0169	0.028	CbGbCtD
Fluvastatin—CYP2D6—Dexamethasone—multiple sclerosis	0.0166	0.0275	CbGbCtD
Fluvastatin—CYP3A4—Dexamethasone—multiple sclerosis	0.0105	0.0175	CbGbCtD
Fluvastatin—Rosuvastatin—ALB—multiple sclerosis	0.00118	0.534	CrCbGaD
Fluvastatin—Pitavastatin—ALB—multiple sclerosis	0.00103	0.466	CrCbGaD
Fluvastatin—Angioedema—Dexamethasone—multiple sclerosis	0.000285	0.000971	CcSEcCtD
Fluvastatin—Angioedema—Betamethasone—multiple sclerosis	0.000285	0.000971	CcSEcCtD
Fluvastatin—Angiopathy—Prednisone—multiple sclerosis	0.000283	0.000965	CcSEcCtD
Fluvastatin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000282	0.000962	CcSEcCtD
Fluvastatin—Confusional state—Methylprednisolone—multiple sclerosis	0.000282	0.000962	CcSEcCtD
Fluvastatin—Immune system disorder—Prednisone—multiple sclerosis	0.000282	0.00096	CcSEcCtD
Fluvastatin—Malaise—Dexamethasone—multiple sclerosis	0.000281	0.000958	CcSEcCtD
Fluvastatin—Malaise—Betamethasone—multiple sclerosis	0.000281	0.000958	CcSEcCtD
Fluvastatin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00028	0.000956	CcSEcCtD
Fluvastatin—Vertigo—Betamethasone—multiple sclerosis	0.00028	0.000955	CcSEcCtD
Fluvastatin—Vertigo—Dexamethasone—multiple sclerosis	0.00028	0.000955	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00028	0.000954	CcSEcCtD
Fluvastatin—Syncope—Betamethasone—multiple sclerosis	0.000279	0.000953	CcSEcCtD
Fluvastatin—Syncope—Dexamethasone—multiple sclerosis	0.000279	0.000953	CcSEcCtD
Fluvastatin—Arrhythmia—Prednisone—multiple sclerosis	0.000279	0.00095	CcSEcCtD
Fluvastatin—Infection—Triamcinolone—multiple sclerosis	0.000278	0.00095	CcSEcCtD
Fluvastatin—Sweating—Methotrexate—multiple sclerosis	0.000278	0.000949	CcSEcCtD
Fluvastatin—Infection—Methylprednisolone—multiple sclerosis	0.000278	0.000948	CcSEcCtD
Fluvastatin—Shock—Triamcinolone—multiple sclerosis	0.000276	0.00094	CcSEcCtD
Fluvastatin—Insomnia—Prednisolone—multiple sclerosis	0.000276	0.00094	CcSEcCtD
Fluvastatin—Alopecia—Prednisone—multiple sclerosis	0.000276	0.000939	CcSEcCtD
Fluvastatin—Shock—Methylprednisolone—multiple sclerosis	0.000275	0.000938	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000275	0.000936	CcSEcCtD
Fluvastatin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000274	0.000935	CcSEcCtD
Fluvastatin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000274	0.000934	CcSEcCtD
Fluvastatin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000274	0.000934	CcSEcCtD
Fluvastatin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000274	0.000933	CcSEcCtD
Fluvastatin—Paraesthesia—Prednisolone—multiple sclerosis	0.000274	0.000933	CcSEcCtD
Fluvastatin—Mental disorder—Prednisone—multiple sclerosis	0.000273	0.000931	CcSEcCtD
Fluvastatin—Nausea—Azathioprine—multiple sclerosis	0.000273	0.000931	CcSEcCtD
Fluvastatin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000272	0.000926	CcSEcCtD
Fluvastatin—Erythema—Prednisone—multiple sclerosis	0.000271	0.000926	CcSEcCtD
Fluvastatin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000271	0.000924	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00027	0.000922	CcSEcCtD
Fluvastatin—Hypertension—Betamethasone—multiple sclerosis	0.000269	0.000918	CcSEcCtD
Fluvastatin—Hypertension—Dexamethasone—multiple sclerosis	0.000269	0.000918	CcSEcCtD
Fluvastatin—Asthenia—Mitoxantrone—multiple sclerosis	0.000267	0.000909	CcSEcCtD
Fluvastatin—Myalgia—Betamethasone—multiple sclerosis	0.000265	0.000905	CcSEcCtD
Fluvastatin—Myalgia—Dexamethasone—multiple sclerosis	0.000265	0.000905	CcSEcCtD
Fluvastatin—Anxiety—Dexamethasone—multiple sclerosis	0.000264	0.000902	CcSEcCtD
Fluvastatin—Anxiety—Betamethasone—multiple sclerosis	0.000264	0.000902	CcSEcCtD
Fluvastatin—Discomfort—Dexamethasone—multiple sclerosis	0.000262	0.000894	CcSEcCtD
Fluvastatin—Discomfort—Betamethasone—multiple sclerosis	0.000262	0.000894	CcSEcCtD
Fluvastatin—Pain—Prednisolone—multiple sclerosis	0.000261	0.000889	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—multiple sclerosis	0.000261	0.000889	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—multiple sclerosis	0.000259	0.000882	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000255	0.000871	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000255	0.000869	CcSEcCtD
Fluvastatin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000254	0.000867	CcSEcCtD
Fluvastatin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000254	0.000867	CcSEcCtD
Fluvastatin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000254	0.000867	CcSEcCtD
Fluvastatin—Insomnia—Triamcinolone—multiple sclerosis	0.000254	0.000865	CcSEcCtD
Fluvastatin—Insomnia—Methylprednisolone—multiple sclerosis	0.000253	0.000863	CcSEcCtD
Fluvastatin—Infection—Betamethasone—multiple sclerosis	0.000253	0.000862	CcSEcCtD
Fluvastatin—Infection—Dexamethasone—multiple sclerosis	0.000253	0.000862	CcSEcCtD
Fluvastatin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000252	0.000859	CcSEcCtD
Fluvastatin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000252	0.000858	CcSEcCtD
Fluvastatin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000251	0.000857	CcSEcCtD
Fluvastatin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000251	0.000856	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—multiple sclerosis	0.000251	0.000856	CcSEcCtD
Fluvastatin—Shock—Betamethasone—multiple sclerosis	0.00025	0.000853	CcSEcCtD
Fluvastatin—Shock—Dexamethasone—multiple sclerosis	0.00025	0.000853	CcSEcCtD
Fluvastatin—Dyspnoea—Triamcinolone—multiple sclerosis	0.00025	0.000852	CcSEcCtD
Fluvastatin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000249	0.000851	CcSEcCtD
Fluvastatin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000249	0.000851	CcSEcCtD
Fluvastatin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000249	0.000849	CcSEcCtD
Fluvastatin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000249	0.000849	CcSEcCtD
Fluvastatin—Angioedema—Prednisone—multiple sclerosis	0.000248	0.000846	CcSEcCtD
Fluvastatin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000247	0.000841	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000246	0.00084	CcSEcCtD
Fluvastatin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000246	0.00084	CcSEcCtD
Fluvastatin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000246	0.000838	CcSEcCtD
Fluvastatin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000246	0.000838	CcSEcCtD
Fluvastatin—Malaise—Prednisone—multiple sclerosis	0.000245	0.000835	CcSEcCtD
Fluvastatin—Vertigo—Prednisone—multiple sclerosis	0.000244	0.000832	CcSEcCtD
Fluvastatin—Syncope—Prednisone—multiple sclerosis	0.000243	0.00083	CcSEcCtD
Fluvastatin—Anorexia—Dexamethasone—multiple sclerosis	0.000242	0.000827	CcSEcCtD
Fluvastatin—Anorexia—Betamethasone—multiple sclerosis	0.000242	0.000827	CcSEcCtD
Fluvastatin—Urticaria—Prednisolone—multiple sclerosis	0.000242	0.000826	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—multiple sclerosis	0.000242	0.000825	CcSEcCtD
Fluvastatin—Fatigue—Triamcinolone—multiple sclerosis	0.000242	0.000824	CcSEcCtD
Fluvastatin—Fatigue—Methylprednisolone—multiple sclerosis	0.000241	0.000822	CcSEcCtD
Fluvastatin—Pain—Triamcinolone—multiple sclerosis	0.00024	0.000817	CcSEcCtD
Fluvastatin—Loss of consciousness—Prednisone—multiple sclerosis	0.000239	0.000813	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—multiple sclerosis	0.000236	0.000806	CcSEcCtD
Fluvastatin—Vomiting—Mitoxantrone—multiple sclerosis	0.000236	0.000806	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—multiple sclerosis	0.000235	0.000803	CcSEcCtD
Fluvastatin—Hypertension—Prednisone—multiple sclerosis	0.000234	0.000799	CcSEcCtD
Fluvastatin—Rash—Mitoxantrone—multiple sclerosis	0.000234	0.000799	CcSEcCtD
Fluvastatin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000234	0.000798	CcSEcCtD
Fluvastatin—Chills—Methotrexate—multiple sclerosis	0.000234	0.000797	CcSEcCtD
Fluvastatin—Headache—Mitoxantrone—multiple sclerosis	0.000233	0.000794	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000232	0.00079	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000232	0.00079	CcSEcCtD
Fluvastatin—Arthralgia—Prednisone—multiple sclerosis	0.000231	0.000788	CcSEcCtD
Fluvastatin—Myalgia—Prednisone—multiple sclerosis	0.000231	0.000788	CcSEcCtD
Fluvastatin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000231	0.000788	CcSEcCtD
Fluvastatin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00023	0.000786	CcSEcCtD
Fluvastatin—Anxiety—Prednisone—multiple sclerosis	0.00023	0.000785	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—multiple sclerosis	0.00023	0.000785	CcSEcCtD
Fluvastatin—Insomnia—Betamethasone—multiple sclerosis	0.00023	0.000784	CcSEcCtD
Fluvastatin—Insomnia—Dexamethasone—multiple sclerosis	0.00023	0.000784	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000229	0.000783	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000229	0.00078	CcSEcCtD
Fluvastatin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000228	0.000779	CcSEcCtD
Fluvastatin—Paraesthesia—Betamethasone—multiple sclerosis	0.000228	0.000779	CcSEcCtD
Fluvastatin—Discomfort—Prednisone—multiple sclerosis	0.000228	0.000778	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—multiple sclerosis	0.000228	0.000778	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—multiple sclerosis	0.000227	0.000773	CcSEcCtD
Fluvastatin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000225	0.000766	CcSEcCtD
Fluvastatin—Dyspepsia—Betamethasone—multiple sclerosis	0.000224	0.000763	CcSEcCtD
Fluvastatin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000224	0.000763	CcSEcCtD
Fluvastatin—Urticaria—Triamcinolone—multiple sclerosis	0.000223	0.000759	CcSEcCtD
Fluvastatin—Urticaria—Methylprednisolone—multiple sclerosis	0.000222	0.000758	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—multiple sclerosis	0.000222	0.000757	CcSEcCtD
Fluvastatin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000222	0.000756	CcSEcCtD
Fluvastatin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000222	0.000755	CcSEcCtD
Fluvastatin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000221	0.000754	CcSEcCtD
Fluvastatin—Decreased appetite—Betamethasone—multiple sclerosis	0.000221	0.000754	CcSEcCtD
Fluvastatin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000221	0.000754	CcSEcCtD
Fluvastatin—Nausea—Mitoxantrone—multiple sclerosis	0.000221	0.000753	CcSEcCtD
Fluvastatin—Infection—Prednisone—multiple sclerosis	0.00022	0.00075	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00022	0.000749	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00022	0.000749	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—multiple sclerosis	0.000219	0.000748	CcSEcCtD
Fluvastatin—Fatigue—Dexamethasone—multiple sclerosis	0.000219	0.000748	CcSEcCtD
Fluvastatin—Fatigue—Betamethasone—multiple sclerosis	0.000219	0.000748	CcSEcCtD
Fluvastatin—Shock—Prednisone—multiple sclerosis	0.000218	0.000743	CcSEcCtD
Fluvastatin—Pain—Betamethasone—multiple sclerosis	0.000218	0.000742	CcSEcCtD
Fluvastatin—Pain—Dexamethasone—multiple sclerosis	0.000218	0.000742	CcSEcCtD
Fluvastatin—Nervous system disorder—Prednisone—multiple sclerosis	0.000217	0.000741	CcSEcCtD
Fluvastatin—Skin disorder—Prednisone—multiple sclerosis	0.000215	0.000734	CcSEcCtD
Fluvastatin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000214	0.00073	CcSEcCtD
Fluvastatin—Anorexia—Prednisone—multiple sclerosis	0.000211	0.00072	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00021	0.000718	CcSEcCtD
Fluvastatin—Feeling abnormal—Betamethasone—multiple sclerosis	0.00021	0.000715	CcSEcCtD
Fluvastatin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00021	0.000715	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000208	0.000709	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000208	0.000709	CcSEcCtD
Fluvastatin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000207	0.000704	CcSEcCtD
Fluvastatin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000206	0.000703	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—multiple sclerosis	0.000205	0.000698	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—multiple sclerosis	0.000204	0.000695	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—multiple sclerosis	0.000203	0.000692	CcSEcCtD
Fluvastatin—Urticaria—Dexamethasone—multiple sclerosis	0.000202	0.000689	CcSEcCtD
Fluvastatin—Urticaria—Betamethasone—multiple sclerosis	0.000202	0.000689	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000202	0.000688	CcSEcCtD
Fluvastatin—Dizziness—Prednisolone—multiple sclerosis	0.000202	0.000687	CcSEcCtD
Fluvastatin—Asthenia—Triamcinolone—multiple sclerosis	0.000201	0.000686	CcSEcCtD
Fluvastatin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000201	0.000686	CcSEcCtD
Fluvastatin—Body temperature increased—Betamethasone—multiple sclerosis	0.000201	0.000686	CcSEcCtD
Fluvastatin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000201	0.000686	CcSEcCtD
Fluvastatin—Abdominal pain—Betamethasone—multiple sclerosis	0.000201	0.000686	CcSEcCtD
Fluvastatin—Asthenia—Methylprednisolone—multiple sclerosis	0.000201	0.000684	CcSEcCtD
Fluvastatin—Insomnia—Prednisone—multiple sclerosis	0.0002	0.000683	CcSEcCtD
Fluvastatin—Paraesthesia—Prednisone—multiple sclerosis	0.000199	0.000678	CcSEcCtD
Fluvastatin—Pruritus—Triamcinolone—multiple sclerosis	0.000198	0.000676	CcSEcCtD
Fluvastatin—Cough—Methotrexate—multiple sclerosis	0.000198	0.000675	CcSEcCtD
Fluvastatin—Pruritus—Methylprednisolone—multiple sclerosis	0.000198	0.000675	CcSEcCtD
Fluvastatin—Dyspepsia—Prednisone—multiple sclerosis	0.000195	0.000665	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—multiple sclerosis	0.000193	0.000659	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—multiple sclerosis	0.000193	0.000659	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—multiple sclerosis	0.000193	0.000659	CcSEcCtD
Fluvastatin—Decreased appetite—Prednisone—multiple sclerosis	0.000193	0.000657	CcSEcCtD
Fluvastatin—Rash—Prednisolone—multiple sclerosis	0.000192	0.000655	CcSEcCtD
Fluvastatin—Dermatitis—Prednisolone—multiple sclerosis	0.000192	0.000655	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000192	0.000654	CcSEcCtD
Fluvastatin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000191	0.000653	CcSEcCtD
Fluvastatin—Fatigue—Prednisone—multiple sclerosis	0.000191	0.000651	CcSEcCtD
Fluvastatin—Headache—Prednisolone—multiple sclerosis	0.000191	0.000651	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—multiple sclerosis	0.000191	0.000651	CcSEcCtD
Fluvastatin—Constipation—Prednisone—multiple sclerosis	0.000189	0.000646	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—multiple sclerosis	0.000187	0.000637	CcSEcCtD
Fluvastatin—Dizziness—Triamcinolone—multiple sclerosis	0.000185	0.000632	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000185	0.000631	CcSEcCtD
Fluvastatin—Dizziness—Methylprednisolone—multiple sclerosis	0.000185	0.000631	CcSEcCtD
Fluvastatin—Infection—Methotrexate—multiple sclerosis	0.000184	0.000627	CcSEcCtD
Fluvastatin—Feeling abnormal—Prednisone—multiple sclerosis	0.000183	0.000622	CcSEcCtD
Fluvastatin—Asthenia—Dexamethasone—multiple sclerosis	0.000182	0.000622	CcSEcCtD
Fluvastatin—Asthenia—Betamethasone—multiple sclerosis	0.000182	0.000622	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000182	0.000619	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000181	0.000618	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000181	0.000618	CcSEcCtD
Fluvastatin—Nausea—Prednisolone—multiple sclerosis	0.000181	0.000617	CcSEcCtD
Fluvastatin—Pruritus—Betamethasone—multiple sclerosis	0.00018	0.000614	CcSEcCtD
Fluvastatin—Pruritus—Dexamethasone—multiple sclerosis	0.00018	0.000614	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—multiple sclerosis	0.00018	0.000613	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000179	0.00061	CcSEcCtD
Fluvastatin—Vomiting—Triamcinolone—multiple sclerosis	0.000178	0.000608	CcSEcCtD
Fluvastatin—Vomiting—Methylprednisolone—multiple sclerosis	0.000178	0.000606	CcSEcCtD
Fluvastatin—Rash—Triamcinolone—multiple sclerosis	0.000177	0.000603	CcSEcCtD
Fluvastatin—Dermatitis—Triamcinolone—multiple sclerosis	0.000177	0.000602	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—multiple sclerosis	0.000176	0.000602	CcSEcCtD
Fluvastatin—Rash—Methylprednisolone—multiple sclerosis	0.000176	0.000601	CcSEcCtD
Fluvastatin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000176	0.000601	CcSEcCtD
Fluvastatin—Urticaria—Prednisone—multiple sclerosis	0.000176	0.0006	CcSEcCtD
Fluvastatin—Headache—Triamcinolone—multiple sclerosis	0.000176	0.000599	CcSEcCtD
Fluvastatin—Headache—Methylprednisolone—multiple sclerosis	0.000175	0.000598	CcSEcCtD
Fluvastatin—Abdominal pain—Prednisone—multiple sclerosis	0.000175	0.000597	CcSEcCtD
Fluvastatin—Body temperature increased—Prednisone—multiple sclerosis	0.000175	0.000597	CcSEcCtD
Fluvastatin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000174	0.000593	CcSEcCtD
Fluvastatin—Diarrhoea—Betamethasone—multiple sclerosis	0.000174	0.000593	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000169	0.000575	CcSEcCtD
Fluvastatin—Dizziness—Dexamethasone—multiple sclerosis	0.000168	0.000574	CcSEcCtD
Fluvastatin—Dizziness—Betamethasone—multiple sclerosis	0.000168	0.000574	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—multiple sclerosis	0.000167	0.000571	CcSEcCtD
Fluvastatin—Nausea—Triamcinolone—multiple sclerosis	0.000167	0.000568	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—multiple sclerosis	0.000166	0.000567	CcSEcCtD
Fluvastatin—Nausea—Methylprednisolone—multiple sclerosis	0.000166	0.000567	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—multiple sclerosis	0.000165	0.000563	CcSEcCtD
Fluvastatin—Hypersensitivity—Prednisone—multiple sclerosis	0.000163	0.000557	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—multiple sclerosis	0.000163	0.000556	CcSEcCtD
Fluvastatin—Vomiting—Betamethasone—multiple sclerosis	0.000162	0.000551	CcSEcCtD
Fluvastatin—Vomiting—Dexamethasone—multiple sclerosis	0.000162	0.000551	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—multiple sclerosis	0.000161	0.000549	CcSEcCtD
Fluvastatin—Rash—Betamethasone—multiple sclerosis	0.00016	0.000547	CcSEcCtD
Fluvastatin—Rash—Dexamethasone—multiple sclerosis	0.00016	0.000547	CcSEcCtD
Fluvastatin—Dermatitis—Dexamethasone—multiple sclerosis	0.00016	0.000546	CcSEcCtD
Fluvastatin—Dermatitis—Betamethasone—multiple sclerosis	0.00016	0.000546	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00016	0.000545	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—multiple sclerosis	0.00016	0.000544	CcSEcCtD
Fluvastatin—Headache—Dexamethasone—multiple sclerosis	0.000159	0.000543	CcSEcCtD
Fluvastatin—Headache—Betamethasone—multiple sclerosis	0.000159	0.000543	CcSEcCtD
Fluvastatin—Asthenia—Prednisone—multiple sclerosis	0.000159	0.000542	CcSEcCtD
Fluvastatin—Pain—Methotrexate—multiple sclerosis	0.000158	0.00054	CcSEcCtD
Fluvastatin—Pruritus—Prednisone—multiple sclerosis	0.000157	0.000534	CcSEcCtD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000155	0.0015	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000155	0.0015	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—SRM—multiple sclerosis	0.000154	0.00149	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000153	0.00148	CbGpPWpGaD
Fluvastatin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000153	0.00052	CcSEcCtD
Fluvastatin—Diarrhoea—Prednisone—multiple sclerosis	0.000152	0.000517	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000151	0.000516	CcSEcCtD
Fluvastatin—Nausea—Dexamethasone—multiple sclerosis	0.000151	0.000515	CcSEcCtD
Fluvastatin—Nausea—Betamethasone—multiple sclerosis	0.000151	0.000515	CcSEcCtD
Fluvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000149	0.00144	CbGpPWpGaD
Fluvastatin—Urticaria—Methotrexate—multiple sclerosis	0.000147	0.000501	CcSEcCtD
Fluvastatin—Dizziness—Prednisone—multiple sclerosis	0.000146	0.000499	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—multiple sclerosis	0.000146	0.000499	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—multiple sclerosis	0.000146	0.000499	CcSEcCtD
Fluvastatin—SLCO1B3—Metabolism—SRM—multiple sclerosis	0.000145	0.00141	CbGpPWpGaD
Fluvastatin—UGT1A3—Biological oxidations—POMC—multiple sclerosis	0.000143	0.00138	CbGpPWpGaD
Fluvastatin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000143	0.00138	CbGpPWpGaD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000141	0.00136	CbGpPWpGaD
Fluvastatin—Vomiting—Prednisone—multiple sclerosis	0.000141	0.00048	CcSEcCtD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00014	0.00136	CbGpPWpGaD
Fluvastatin—Rash—Prednisone—multiple sclerosis	0.00014	0.000476	CcSEcCtD
Fluvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00014	0.00135	CbGpPWpGaD
Fluvastatin—Dermatitis—Prednisone—multiple sclerosis	0.00014	0.000476	CcSEcCtD
Fluvastatin—Headache—Prednisone—multiple sclerosis	0.000139	0.000473	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000136	0.000465	CcSEcCtD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000136	0.00131	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—CYP24A1—multiple sclerosis	0.000133	0.00129	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—CYP27B1—multiple sclerosis	0.000133	0.00129	CbGpPWpGaD
Fluvastatin—Asthenia—Methotrexate—multiple sclerosis	0.000133	0.000453	CcSEcCtD
Fluvastatin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000132	0.00128	CbGpPWpGaD
Fluvastatin—Nausea—Prednisone—multiple sclerosis	0.000132	0.000449	CcSEcCtD
Fluvastatin—UGT2B7—Metabolism—SRM—multiple sclerosis	0.000131	0.00127	CbGpPWpGaD
Fluvastatin—Pruritus—Methotrexate—multiple sclerosis	0.000131	0.000447	CcSEcCtD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00013	0.00126	CbGpPWpGaD
Fluvastatin—Diarrhoea—Methotrexate—multiple sclerosis	0.000127	0.000432	CcSEcCtD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000125	0.00121	CbGpPWpGaD
Fluvastatin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000124	0.0012	CbGpPWpGaD
Fluvastatin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000124	0.0012	CbGpPWpGaD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000124	0.0012	CbGpPWpGaD
Fluvastatin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000122	0.00119	CbGpPWpGaD
Fluvastatin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000122	0.00119	CbGpPWpGaD
Fluvastatin—Dizziness—Methotrexate—multiple sclerosis	0.000122	0.000417	CcSEcCtD
Fluvastatin—HMGCR—Metabolism—GPC5—multiple sclerosis	0.000122	0.00118	CbGpPWpGaD
Fluvastatin—UGT2B7—Biological oxidations—POMC—multiple sclerosis	0.000122	0.00118	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000121	0.00117	CbGpPWpGaD
Fluvastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000121	0.00117	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000121	0.00117	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00012	0.00116	CbGpPWpGaD
Fluvastatin—Vomiting—Methotrexate—multiple sclerosis	0.000118	0.000401	CcSEcCtD
Fluvastatin—Rash—Methotrexate—multiple sclerosis	0.000117	0.000398	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—multiple sclerosis	0.000117	0.000398	CcSEcCtD
Fluvastatin—Headache—Methotrexate—multiple sclerosis	0.000116	0.000395	CcSEcCtD
Fluvastatin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000116	0.00112	CbGpPWpGaD
Fluvastatin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000113	0.0011	CbGpPWpGaD
Fluvastatin—SLCO2B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000113	0.00109	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000113	0.00109	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.00011	0.00107	CbGpPWpGaD
Fluvastatin—Nausea—Methotrexate—multiple sclerosis	0.00011	0.000375	CcSEcCtD
Fluvastatin—UGT1A3—Metabolism—CYP24A1—multiple sclerosis	0.000109	0.00105	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—CYP27B1—multiple sclerosis	0.000109	0.00105	CbGpPWpGaD
Fluvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000108	0.00104	CbGpPWpGaD
Fluvastatin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000107	0.00103	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—SRM—multiple sclerosis	0.000107	0.00103	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	0.000102	0.000992	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	0.000102	0.000992	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—RRM1—multiple sclerosis	0.000101	0.000979	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.0001	0.00097	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—GPC5—multiple sclerosis	9.95e-05	0.000963	CbGpPWpGaD
Fluvastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.92e-05	0.000961	CbGpPWpGaD
Fluvastatin—UGT1A1—Biological oxidations—POMC—multiple sclerosis	9.89e-05	0.000957	CbGpPWpGaD
Fluvastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.84e-05	0.000952	CbGpPWpGaD
Fluvastatin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.8e-05	0.000948	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—SRM—multiple sclerosis	9.77e-05	0.000946	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.69e-05	0.000938	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.69e-05	0.000938	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.47e-05	0.000917	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	9.43e-05	0.000912	CbGpPWpGaD
Fluvastatin—UGT1A3—NRF2 pathway—TGFB1—multiple sclerosis	9.41e-05	0.00091	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	9.4e-05	0.00091	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—GPC5—multiple sclerosis	9.37e-05	0.000907	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CYP27B1—multiple sclerosis	9.25e-05	0.000895	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CYP24A1—multiple sclerosis	9.25e-05	0.000895	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	9.22e-05	0.000893	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.89e-05	0.00086	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.89e-05	0.00086	CbGpPWpGaD
Fluvastatin—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8.83e-05	0.000855	CbGpPWpGaD
Fluvastatin—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8.79e-05	0.00085	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	8.78e-05	0.00085	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	8.78e-05	0.00085	CbGpPWpGaD
Fluvastatin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.75e-05	0.000847	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	8.65e-05	0.000837	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—GPC5—multiple sclerosis	8.46e-05	0.000819	CbGpPWpGaD
Fluvastatin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.41e-05	0.000814	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.38e-05	0.000811	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—RRM1—multiple sclerosis	8.24e-05	0.000798	CbGpPWpGaD
Fluvastatin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.04e-05	0.000779	CbGpPWpGaD
Fluvastatin—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	8e-05	0.000774	CbGpPWpGaD
Fluvastatin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.98e-05	0.000772	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.93e-05	0.000768	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.93e-05	0.000768	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.85e-05	0.000759	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—RRM1—multiple sclerosis	7.77e-05	0.000752	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.72e-05	0.000747	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.69e-05	0.000744	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	7.52e-05	0.000727	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	7.52e-05	0.000727	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.23e-05	0.0007	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.23e-05	0.0007	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—RRM1—multiple sclerosis	7.01e-05	0.000678	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	6.89e-05	0.000667	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	6.89e-05	0.000667	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GPC5—multiple sclerosis	6.87e-05	0.000665	CbGpPWpGaD
Fluvastatin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.82e-05	0.00066	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.74e-05	0.000652	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.73e-05	0.000651	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—SRM—multiple sclerosis	6.63e-05	0.000642	CbGpPWpGaD
Fluvastatin—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	6.5e-05	0.000629	CbGpPWpGaD
Fluvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.49e-05	0.000628	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—SRM—multiple sclerosis	6.48e-05	0.000628	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GPC5—multiple sclerosis	6.3e-05	0.00061	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.18e-05	0.000598	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.18e-05	0.000598	CbGpPWpGaD
Fluvastatin—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.15e-05	0.000595	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.14e-05	0.000595	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—SRM—multiple sclerosis	6.13e-05	0.000593	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.03e-05	0.000583	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.01e-05	0.000582	CbGpPWpGaD
Fluvastatin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.01e-05	0.000582	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6e-05	0.00058	CbGpPWpGaD
Fluvastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.93e-05	0.000574	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.88e-05	0.000569	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—BCHE—multiple sclerosis	5.81e-05	0.000562	CbGpPWpGaD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.75e-05	0.000556	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—RRM1—multiple sclerosis	5.7e-05	0.000551	CbGpPWpGaD
Fluvastatin—CYP1A1—Biological oxidations—POMC—multiple sclerosis	5.68e-05	0.00055	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—SRM—multiple sclerosis	5.62e-05	0.000544	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.6e-05	0.000542	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.6e-05	0.000542	CbGpPWpGaD
Fluvastatin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.26e-05	0.000509	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—RRM1—multiple sclerosis	5.22e-05	0.000505	CbGpPWpGaD
Fluvastatin—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.21e-05	0.000504	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.18e-05	0.000501	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—SRM—multiple sclerosis	5.01e-05	0.000485	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—BCHE—multiple sclerosis	4.73e-05	0.000458	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.72e-05	0.000457	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	4.67e-05	0.000452	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	4.67e-05	0.000452	CbGpPWpGaD
Fluvastatin—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.65e-05	0.00045	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—SRM—multiple sclerosis	4.61e-05	0.000446	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—SRM—multiple sclerosis	4.57e-05	0.000442	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.57e-05	0.000442	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.57e-05	0.000442	CbGpPWpGaD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.49e-05	0.000434	CbGpPWpGaD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.47e-05	0.000432	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—BCHE—multiple sclerosis	4.46e-05	0.000432	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	4.32e-05	0.000418	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	4.32e-05	0.000418	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.28e-05	0.000414	CbGpPWpGaD
Fluvastatin—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.27e-05	0.000414	CbGpPWpGaD
Fluvastatin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.24e-05	0.00041	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.22e-05	0.000408	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.18e-05	0.000404	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.05e-05	0.000392	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—BCHE—multiple sclerosis	4.03e-05	0.00039	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.96e-05	0.000383	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.96e-05	0.000383	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GPC5—multiple sclerosis	3.95e-05	0.000382	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—SRM—multiple sclerosis	3.91e-05	0.000378	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.87e-05	0.000374	CbGpPWpGaD
Fluvastatin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.62e-05	0.00035	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.62e-05	0.00035	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.54e-05	0.000343	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.53e-05	0.000342	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.53e-05	0.000342	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—APOE—multiple sclerosis	3.49e-05	0.000338	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.48e-05	0.000337	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.46e-05	0.000335	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.45e-05	0.000334	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—BCHE—multiple sclerosis	3.27e-05	0.000317	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—RRM1—multiple sclerosis	3.27e-05	0.000317	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.25e-05	0.000314	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.25e-05	0.000314	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.23e-05	0.000313	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.22e-05	0.000312	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.22e-05	0.000312	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.17e-05	0.000307	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.15e-05	0.000305	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.02e-05	0.000292	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—SRM—multiple sclerosis	3.01e-05	0.000292	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—POMC—multiple sclerosis	3e-05	0.000291	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—RRM1—multiple sclerosis	3e-05	0.00029	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—BCHE—multiple sclerosis	3e-05	0.00029	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.97e-05	0.000288	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.95e-05	0.000285	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—APOE—multiple sclerosis	2.85e-05	0.000276	CbGpPWpGaD
Fluvastatin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.79e-05	0.00027	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.75e-05	0.000266	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.75e-05	0.000266	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—ALB—multiple sclerosis	2.74e-05	0.000265	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.69e-05	0.00026	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—APOE—multiple sclerosis	2.68e-05	0.00026	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.68e-05	0.000259	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.54e-05	0.000246	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.52e-05	0.000244	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.46e-05	0.000238	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—POMC—multiple sclerosis	2.45e-05	0.000237	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.44e-05	0.000236	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—APOE—multiple sclerosis	2.42e-05	0.000234	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.33e-05	0.000225	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—POMC—multiple sclerosis	2.31e-05	0.000223	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—ALB—multiple sclerosis	2.23e-05	0.000216	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.18e-05	0.000211	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.12e-05	0.000206	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.12e-05	0.000206	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—ALB—multiple sclerosis	2.1e-05	0.000203	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.09e-05	0.000202	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—POMC—multiple sclerosis	2.08e-05	0.000201	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.08e-05	0.000201	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.03e-05	0.000197	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2e-05	0.000193	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.99e-05	0.000192	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.99e-05	0.000192	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—APOE—multiple sclerosis	1.97e-05	0.00019	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.94e-05	0.000188	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—ALB—multiple sclerosis	1.9e-05	0.000184	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.89e-05	0.000183	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.88e-05	0.000182	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.82e-05	0.000176	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.8e-05	0.000175	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.78e-05	0.000173	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.72e-05	0.000167	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—POMC—multiple sclerosis	1.69e-05	0.000164	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.63e-05	0.000157	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.63e-05	0.000157	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.62e-05	0.000157	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.61e-05	0.000156	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.55e-05	0.00015	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ALB—multiple sclerosis	1.54e-05	0.000149	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.54e-05	0.000149	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.48e-05	0.000144	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.41e-05	0.000137	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.41e-05	0.000137	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.4e-05	0.000136	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.39e-05	0.000135	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.27e-05	0.000123	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—APOE—multiple sclerosis	1.22e-05	0.000118	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000116	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000116	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—APOE—multiple sclerosis	1.13e-05	0.000109	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—POMC—multiple sclerosis	1.05e-05	0.000102	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—APOE—multiple sclerosis	1.04e-05	0.0001	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—POMC—multiple sclerosis	1.03e-05	9.95e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—POMC—multiple sclerosis	9.71e-06	9.4e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ALB—multiple sclerosis	9.59e-06	9.28e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ALB—multiple sclerosis	9.37e-06	9.07e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—APOE—multiple sclerosis	9.25e-06	8.95e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.25e-06	8.95e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—POMC—multiple sclerosis	8.9e-06	8.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ALB—multiple sclerosis	8.85e-06	8.57e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—APOE—multiple sclerosis	8.51e-06	8.23e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—APOE—multiple sclerosis	8.43e-06	8.16e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ALB—multiple sclerosis	8.12e-06	7.86e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—POMC—multiple sclerosis	7.95e-06	7.69e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—POMC—multiple sclerosis	7.31e-06	7.07e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—POMC—multiple sclerosis	7.24e-06	7.01e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ALB—multiple sclerosis	7.24e-06	7.01e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—APOE—multiple sclerosis	7.21e-06	6.98e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ALB—multiple sclerosis	6.66e-06	6.45e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ALB—multiple sclerosis	6.61e-06	6.39e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—POMC—multiple sclerosis	6.19e-06	5.99e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ALB—multiple sclerosis	5.64e-06	5.46e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—APOE—multiple sclerosis	5.56e-06	5.38e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—POMC—multiple sclerosis	4.78e-06	4.62e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ALB—multiple sclerosis	4.36e-06	4.22e-05	CbGpPWpGaD
